CEO Bruce Cozadd emphasized that Jazz remains “confident in its revenue guidance of $4.0 to $4.1 billion” for the full year.
Jazz Pharmaceuticals Reports Strong Q3: Will Debt Weigh On Its Future Growth?
Where Today's News Shapes Tomorrow
March 6, 2026
Headlines
